Evidence map›Paper›PMID 31620002›Full record

ArticleFrontiers in pharmacology2019

Spondyloarthritis Patients Suffer Increased Risk of Renal Complications Compared With General Population: A Retrospective Observational Study.

Min Xiao, Qing Lv, Yanli Zhang, Liudan Tu, Mingcan Yang, Zhiming Lin, Zetao Liao, Yutong Jiang, Xuqi Zheng, Xiaomin Li and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Min XiaoDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Qing LvDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yanli ZhangDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Liudan TuDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Mingcan YangDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Zhiming LinDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Zetao LiaoDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yutong JiangDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xuqi ZhengDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xiaomin LiDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Qiujing WeiDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Shuangyan CaoDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Jieruo GuDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Sun Yat-sen University · CNThird Affiliated Hospital of Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to identify the prevalence and risk factors of renal complications of spondyloarthritis (SpA) patients, and to assess increased risks compared to general people. We conducted a retrospective study enrolled with consecutive SpA patients from an inpatient department and age, sex-matched general population (GP). The renal disorders investigated in this study contained decreased estimated glomerular filtration rate (eGFR), hematuria, proteinuria and nephrolithiasis. A total of 350 admitted SpA patients with complete medical records and 323 age and sex-matched GP were enrolled. Most SpA patients were male (n = 283, 80.9%) and the mean age was 31.61 ± 10.73 years old. Among 350 SpA patients, 29 (8.8%) suffered from hematuria, six (1.8%) suffered from proteinuria, one (0.3%) had decreased eGFR, and 27 (13.0%) presented with nephrolithiasis. The relative risk (RR) of nephrolithiasis in SpA compared to the GP was 2.24 (95% CI, 1.00-4.98), and the RR of renal insufficiency was 2.04 (95% CI, 1.11-3.77). In a univariate analysis, nephrolithiasis was significantly associated with age, age of onset, smoking, extra-articular manifestation and a bamboo spine. Renal insufficiency was significantly associated with age, peripheral manifestation, serum albumin, C-reactive protein and erythrocyte sedimentation rate. In a multivariable analysis, only extra-articular manifestation (OR = 8.43, 95% CI, 1.65-43.06, p = 0.010) and bamboo spine (OR = 3.47, 95% CI, 1.01-12.06, p = 0.049) remained significantly associated with nephrolithiasis. However, no variable was recognized as an independent risk factor for renal insufficiency. Renal complications are more common in SpA patients, with more than two-fold increased risk compared with GP. Extra-articular manifestation and bamboo spine are independent risk factors of renal disease in SpA patients.

Indexed as

nephrolithiasisrenal insufficiencyretrospective studyrisk factorsspondyloarthritis

Identifiers

PMID31620002
PMCPMC6759995
OpenAlexW2969337706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.